Systemic mesenchymal stem cells reduce growth rate of cisplatin-resistant ovarian cancer (Q35042364)

6 August 2017

Systemic mesenchymal stem cells reduce growth rate of cisplatin-resistant ovarian cancer (English)

1 reference

6 August 2017

1 reference

mesenchymal stem cell

1 reference

Pengfei Zhu

1

1 reference

6 August 2017

Mo Chen

2

1 reference

6 August 2017

Li Wang

3

1 reference

6 August 2017

Yanxia Ning

4

1 reference

6 August 2017

Jie Liang

5

1 reference

6 August 2017

Hao Zhang

6

1 reference

6 August 2017

Congjian Xu

7

1 reference

6 August 2017

Sifeng Chen

8

1 reference

6 August 2017

Liangqing Yao

9

1 reference

6 August 2017

15 October 2013

1 reference

International Journal of Clinical and Experimental Pathology

6 August 2017

1 reference

6 August 2017

6

1 reference

6 August 2017

11

1 reference

6 August 2017

2506-2514

1 reference

Latest research and treatment of advanced-stage epithelial ovarian cancer

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816820

Evaluation of characteristics of CD44+CD117+ ovarian cancer stem cells in three dimensional basement membrane extract scaffold versus two dimensional monocultures

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816820

Cells, stem cells, and cancer stem cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816820

Epithelial E- and P-cadherins: role and clinical significance in cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816820

Multipotent mesenchymal stromal cells and the innate immune system

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816820

Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816820

MicroRNA-193 pro-proliferation effects for bone mesenchymal stem cells after low-level laser irradiation treatment through inhibitor of growth family, member 5

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816820

Clinical trials for stem cell therapies

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816820

Cellular and biomolecular responses of human ovarian cancer cells to cytostatic dinuclear platinum(II) complexes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816820

Mesenchymal stem cells at the intersection of cell and gene therapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816820

Mesenchymal stem cells and cancer: tumor-specific delivery vehicles or therapeutic targets?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816820

The utility of cells as vehicles for oncolytic virus therapies.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816820

Non platinum metal complexes as anti-cancer drugs

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816820

Molecular targets of ovarian carcinomas with acquired resistance to platinum/taxane chemotherapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816820

Biomolecular targets for platinum antitumor drugs

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816820

Sequential assessment of multidrug resistance phenotype and measurement of S-phase fraction as predictive markers of breast cancer response to neoadjuvant chemotherapy.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816820

The implications of angiogenesis for the biology and therapy of cancer metastasis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816820

The effect of height and weight adjusted dose of intrathecal hyperbaric bupivacaine for elective caesarean section

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816820

Intravenous administration of bone marrow mesenchymal stromal cells is safe for the lung in a chronic myocardial infarction model.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816820

Kinetics of cisplatin-induced apoptosis in murine mammary and ovarian adenocarcinomas

25 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24228113

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Aggressive surgical effort and improved survival in advanced-stage ovarian cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24228113

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Carcinoma of the ovary

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24228113

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

PMCID

3816820

1 reference

6 August 2017

1 reference